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ABSTRACT  Omi, also known as HtrA2, is a mammalian pro-apoptotic mitochondrial protein and a member of the HtrA (high temperature requirement A) family of serine proteases. Omi promotes the caspase-dependent apoptotic pathway through cleavage of IAPs (inhibitor of apoptosis proteins); this cleavage inactivates IAPs and facilitates caspase activity. Omi’s proteolytic activity is necessary and essential for its pro-apoptotic function. This study is aimed to further understand the role of Omi in the cytoplasm by using the yeast two-hybrid system to identify novel Omi interactors/substrates. A HeLa (cervical carcinoma cell line) cDNA library was screened using Omi as a “bait” protein.  One of the proteins indentified in this screen as a strong Omi interactor was the S5a protein and was selected for further analysis.  S5a is a soluble cytosolic mammalian protein and a component of the proteasome’s 19S regulatory subunit. The proteasome is a large cytosolic protein complex responsible for the controlled degradation of damaged or denatured cellular proteins.  Further characterization of the interaction through an in vitro proteolytic assay demonstrated that Omi can cleaves recombinant S5a protein. This data suggests that S5a is a bona fide substrate of Omi that is degraded upon induction of apoptosis. It also provides a new mechanism that leads to the inactivation of the proteasome during cell death. 
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INTRODUCTION  
Omi/HtrA2 is a mammalian mitochondrial serine protease that displays homology to the 
bacterial high temperature requirement A (HtrA) protein family (1).  Omi was first identified 
through the use of the yeast-two hybrid system as a specific interactor of Mxi2, which is an 
alternatively spliced form of the stress activated kinase p38 (2).  Upon induction of apoptosis, 
Omi translocates to the cytoplasm and activates the caspase-dependent apoptotic pathway.  The 
pro-apoptotic activity of Omi is entirely dependent on its proteolytic activity (3).    
 Omi promotes the caspase-dependent apoptotic pathway through targeted binding and 
cleavage of IAPs (Inhibitor of Apoptosis Proteins).   This irreversible cleavage of IAP’s results 
in the inability of those proteins to inhibit caspases (4).  Besides IAP proteins, Omi has been 
shown to cleave various other substrates including Hax-1, Ped/pea-15 (5,6).  These published 
data suggests Omi cleaves multiple known and possibly several unknown substrate proteins. 
Caspase activation has previously been shown to inhibit proteasome function during 
apoptosis (7).  The 26S proteasome is a large cytosolic protein complex responsible for the 
controlled degradation of ubiquitinated-protein conjugates derived from both the nucleus and 
cytosol.  The 26S Proteasome consists of two distinct sub-complexes, the 20S core particle (CP) 
and two 19S regulatory particles (RP) located on either side of the 20S core.  Proteasome activity 
is essential in regulating cellular processes such as cell cycle progression, antigen processing and 
transcription.  Another key role of the proteasome is the regulation of apoptosis through 
degradation of pro-apoptotic signals.  Caspase activation results in cleavage of 3 subunits of the 
19S regulatory sub-complex: S1, S2 and S5a.  The cleavage of these subunits inhibits 
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proteasome degradation of ubiquitinated substrates including pro-apoptotic proteins that are then 
able to upregulate the apoptotic pathways (7,8). 
S5a is a cytosolic protein that appears in a free form as well as a non-ATPase component 
of the 26S proteasome’s 19S regulatory sub-complex.  S5a is composed of two distinct 
functional domains: a von Willebrand A (vWA) domain and two separate Ubiquitin-interacting 
motifs (UIMs).  These UIMs facilitate an interaction between S5a and polyubiquitinated 
proteasome substrates.  S5a serves as a docking site for the proteasome to which the shuttling 
proteins, Rad23 and Dsk2, transport specific ubiquitin-protein conjugates.  This docking 
interaction between S5a and ubiquitinylated proteins facilitates the unfolding of these proteins by 
other 19S RP subunits, and prepares them for degradation by the 20S CP (9). 
Studies have shown that S5a is regulated at the transcriptional level during apoptosis by 
the Src family of kinases; this kinase activity has been implicated in the activation of 
transcription factors that upregulate expression of anti-apoptotic genes.  The upregulation of S5a 
contributes to cell rescue and survival under conditions that promote cell death (10). 
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MATERIALS AND METHODS 
 
Polymerase Chain Reaction (PCR) 
For the amplification of a target DNA sequence, a PCR reaction was performed using 
forward and reverse primers that flank the mature Omi cDNA sequence, coding for amino acids 
134-458, and contain specific restriction sites for cloning purposes. 20 ng of template DNA, 10 
nM in 1 μl of reverse and forward primers respectively, 5 μl of 10X PCR Buffer + Mg2+, 1.5 
units in 1μl of TAQ polymerase, 10 μM of dNTPs were brought to a final volume of 50 μl with 
sterile water.  This reaction mixture was made in duplicate and these were placed in a thermal 
cycler to facilitate PCR reaction. The program used included: denaturation for two minutes at 
95°C and then 30 cycles of the following: denatured at 95°C for 30 seconds, annealed between 
55-60°C (dependent on primers) for 30 seconds and elongated at 72°C for 90 seconds.  The last 
step lasted for 7 minutes. The duplicate mixtures were combined and precipitated to isolate PCR 
product. 
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DNA Precipitation 
To precipitate DNA 3M Sodium Acetate, pH 5.5  (1/10 volume of the DNA solution) and 
2.5X volume of 100 % ethanol was used.  The sample was mixed well by inversion and stored at 
-20°C for at least 20 minutes to allow DNA to precipitate. The sample was then centrifuged 
(13,000 RPM) at 4°C for 20 minutes; the supernatant was discarded upon completion of 
centrifugation.  300µl of 70 % ethanol was added to wash any residual salt from the pellet, and 
the solution was centrifuged (13,000 RPM) for 5 minutes at 4°C.  The supernatant was discarded 
and the pellet was dried for 5 minutes in a speed vacuum. The DNA was resuspended in 50μl of 
dH2O or TE. 
 
 
Restriction Enzyme Digestion 
Restriction enzyme digestion was performed to prepare DNA for ligation into the vector. 
Double-stranded DNA was incubated at 37°C for a period of 1-4 hours depending on the 
restriction enzyme used. A reaction volume of 50μl was generated containing 5 μl of 10X Buffer 
(specific for the enzyme used), 0.5 μl BSA (10μg/μl), 1 μg of DNA, 1.5 μl of restriction enzyme 
(10 units/μl) and 42 μl of sterile water.  If two sequential digestions were required, the DNA was 
precipitated after the first digestion and then a separate reaction mixture was generated specific 
for the second restriction enzyme. 
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Gel Electrophoresis 
Agarose gel electrophoresis was used to monitor the enzyme digestion of DNA, and to 
determine the yield and purity of DNA Minipreps, or PCR reaction, or to size fractionate DNA 
molecules for isolation. To prepare an agarose gel, 1.0 g of dried agarose (American 
Bioanalytical) was added to 100 ml 1X TAE (0.04 M Tris-acetate, 0.001 M EDTA).  This 
solution was microwaved for 90 seconds until the agarose was completely dissolved. After the 
solution cooled, 5 μl of ethidium bromide was added to generate a final concentration of 0.5 
µg/ml and this solution was poured into a gel tray with well combs to solidify.  After the gel had 
solidified, the combs were gently removed and 1X TAE electrophoresis buffer was added to the 
tray agarose gel was covered.  To prepare the samples for electrophoresis, 5 µl of 10X gel-
loading buffer (30% glycerol (Fisher), 2% Orange G - (Sigma) in 1X TAE) was added to 3-5 µl 
of DNA and this was loaded into a well.  DNA markers (Lambda DNA BstEII Digest) were used 
to determine the size and concentration of the DNA samples.  Electrophoresis was performed at 
50-150V until the dye migrated an appropriate distance through the agarose gel. 
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DNA Ligation 
A DNA insert was ligated into a specific vector following restriction enzyme digestion of 
both the insert and vector DNA.  A ligation reaction mixture of 15 μl was generated with 1.5 μl 
of Ligation Buffer with ATP, 1 μl DNA ligase, x μl of the vector and insert.  The amount of 
DNA used was dependent on the concentration of DNA retrieved after digestion and was 
determined by analysis of the DNA on an electrophoresis gel.  In general, a 1:3 ratio of vector to 
insert DNA was used and sterile water was added to bring the final volume to 15 μl.  This 
reaction mixture was incubated at room temperature for 5 minutes and then transferred to a 70°C 
water bath for 15 minutes to inactivate DNA ligase.  After this step, 35 μl of sterile water was 
added to bring the volume up to 50 μl and then 500 μl of N-butanol was added to precipitate 
DNA.  This mixture was mixed and centrifuged at 4°C (13,000 RPM) for 10 minutes. Following 
centrifugation the supernatant was discarded and the sample was dried in a speedvac for 10 
minutes, the dried sample was then resuspended in 4-6 μl of sterile water.  
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Bacterial Transformation 
Electroporation was used to transform bacteria with plasmid DNA.  An electric pulse 
increases the permeability of the bacterial cell walls and allows for the uptake of plasmid DNA.  
An electroporation cuvette (0.2 cm electrode gap) was cooled to 4°C and 4-6 μl of the DNA 
ligation mix (10 ng) was transferred into 100 μl of competent bacterial cell suspension.  This 
solution was mixed gently, incubated on ice for about 1 minute and then transferred into the 
chilled electroporation cuvette.  The cuvette was placed in the Gene Pulser (BioRad) to deliver a 
single exponential decay pulse of 2.5 kV and then 600 μl of room temperature LB medium was 
added immediately.  The entire mixture was transferred to a sterile 2-ml microcentrifuge tube 
and incubated at 37°C for 1h. Different volumes (150μl and 250μl) of the mixture were plated on 
LB-agar plates, containing the antibiotic that was also the selectable marker in the vector used, 
and were incubated overnight at 37°C.  Single bacterial colonies were then picked and used to 
inoculate 1.5 ml of 50 μl/ml antibiotic (Amp) LB media for DNA Miniprep isolation. 
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Quick Isolation of Plasmid DNA from Bacteria (Miniprep) 
Individual colonies were picked and used to inoculate 2 ml of LB media + Amp.  After an 
overnight incubation at 37°C, the suspensions were transferred to microcentrifuge tubes, and 
centrifuged (13,000 RPM) for 2 minutes.  The supernatant was then aspirated and the pellet re-
suspended in 300 μl of a STET/Lysozyme solution (8% Sucrose, 5% of 100X Triton, 50 mM of 
Tris-HCl, pH 8 and 50 mM of EDTA, 10mg/ml Lysozyme). Samples were placed in a boiling 
water bath for 1 minute and centrifuged (13,000 RPM) for 10 minutes.  Following centrifugation, 
the pellet containing cellular debris was removed with a toothpick and 200 μl of Isopropanol was 
added.  The samples were mixed thoroughly and centrifuged (13,000 RPM) for 10 minutes.  The 
supernatant was then discarded and 300 μl of 70% Ethanol added to wash the pellet during a 5-
minute centrifugation (13,000 RPM). The supernatant was discarded and the DNA pellet dried in 
a Savant speedvac for 10 minutes.  The DNA was re-suspended in 50 μl of TE. 
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Clean DNA QIAprep Isolation of DNA from Bacteria 
This method of Plasmid isolation uses the QIAprep Spin Miniprep Kit according to the 
instructions provided by the manufacturer QIA.  Individual colonies were chosen to inoculate 2 
ml of LB media + Amp and were incubated overnight at 37°C.  These overnight suspensions 
were mixed and transferred to microcentrifuge tubes, which were then centrifuged (11,000 RPM) 
for 2 minutes. The supernatant was aspirated and the pellet was resuspended in 200 μl of 
Resuspension Buffer P1 containing RNase A (100 μg/ml).  200 μl of Lysis Buffer P2 was then 
added and the tubes were then gently inverted 5-6 times to mix and ensure cell lysis.  The lysate 
was neutralized and adjusted to high-salt binding conditions through the addition 300 μl of 
Neutralization Buffer N3.  The sample was immediately mixed for three minutes and then 
centrifuged (13,000 RPM) for 10 minutes.  The supernatant was transferred to a QIAprep spin 
column using a pipette.  The column was centrifuged for 1 minute at 13,000 RPM and the flow-
through was discarded.  The column was washed with 0.50 ml of PB Buffer and centrifuged for 
1 minute at 13,000 RPM, and the flow-through was discarded.  The column was then washed 
with 0.75 ml of PE Buffer and centrifuged for 1 minute at 13,000 RPM.  The flow-through was 
then discarded and the column washed for an additional 1 minute.  The Column was transferred 
to a 1.5 ml microcentrifuge tube and 50 μl of EB buffer (10 mM TrisCl, pH 8.5) was added and 
the column was centrifuged for 1 minute at 13,000 RPM. 
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Yeast-Two Hybrid Screening 
The EGY48 yeast strain was used as the host to screen for two-hybrid interactions.  This 
strain had been transformed with a pSH18-34 plasmid containing an upstream LexA operator, 
and a LacZ reporter gene that directs β-galactosidase synthesis.  The cDNA of specific proteins 
that had been shown to interact previously with Omi were cloned into a pJG4-5 shuttle vector 
that contains a galactose inducible promoter; these served as the prey constructs.   Mature 
Omi134-458 and mature HtrA1156-480 were used as bait constructs and had previously been cloned 
into a pGILDA vector, which also contains a galactose inducible promoter.  This recombinant 
yeast was grown on Ura-His-Trp- Galactose/Rafinose selective media containing X-Gal; positive 
bait-prey interactions were identified by the presence of blue colonies.  The prey protein 
expressed by the colony with the strongest detectable interaction was chosen for further study to 
characterize its interaction with Omi. 
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Protein Expression 
Target DNA sequences encoded for His-Omi134-458 or His-S5aFL were amplified using 
PCR and ligated into a pET vector respectively for use in expressing His-tagged recombinant 
protein.  This plasmid DNA was used to transform BL21(DE3) bacterial cells.  These cells were 
grown overnight on LB-Agar+Kanamycin plates.  Individual colonies were selected and used to 
inoculate 20 ml of LB+Kanamycin media and incubated at 37°C overnight; Kanamycin was 
present at a concentration of 40 μg/ml.  Half (10 ml) of the culture media was then transferred to 
500ml of fresh LB+Kanamycin and grown for 4 hours at 37°C until the optical density at 600nm 
(OD600) reached a value between 0.8-1.2.  The bacteria were induced to express the target protein 
through addition of 500 μl of 1 M IPTG (to a final concentration of 2 mM).  The bacteria were 
induced for 4 hours at 25°C in a shaker to inhibit growth and promote protein expression.  
Bacterial cells were then collected into 250 ml centrifuge tubes and centrifuged at 7000 RPM for 
10 minutes (Sorvall rotor) at 4°C.  The supernatant was then discarded and the cell pellet was 
frozen overnight at -80°C. 
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Protein Isolation 
Lysis buffer was prepared: 8X Binding buffer (2M NaCl, 160 mM 8X Tris pH 8, 40 mM 
Imidazole, 0.4% sodium azide) and was diluted to 1X in 50 ml, bacterial protease inhibitors 
(SIGMA cat. #P2714) were added in a 1:100 concentration, finally 100 μl of lysozyme was also 
included. The frozen pellet was resuspended in 10 ml of lysis buffer; Triton was added to 1% 
final concentration.  The lysate was incubated at 30°C for 20 minutes and vortexed every 5 
minutes to release genomic DNA.  The lysate was then sonicated while on ice to shear the DNA 
and decrease viscosity.   The sonicated lysate was then transferred to a 25 ml centrifuge tube and 
centrifuged at 15,000 RPM (Sorvall rotor) for 40 minutes at 4°C.  The supernatant was collected 
and added to a 50 ml falcon tube containing 1/10 the volume of Ni-NTA agarose resin.  The 
falcon tube was rotated for 4 hours at 4°C.  The protein-resin mixture was then added to a flow-
through column for purification of the His-tagged protein of interest.  The column was washed 
with 20X column volume of 1X Binding buffer, then 20X column volume of 1X Washing buffer 
(2 M NaCl, 160 mM Tris-HCl pH 8, 480 mM 8X Imidazole, 0.4% sodium azide).  After all of 
the Washing buffer had passed through the column 10X column volume of 1X Elution buffer (1 
M NaCl, 2 M 4X Imidazole, 80 mM Tris-HCl pH8, 0.2% sodium azide) was added and 3X 1.5 
ml elution fractions were collected.  Each fraction was transferred into dialysis tubing and the 
tubes dialyzed overnight at 4°C in a 2 L beaker containing Dialysis buffer (20 mM Tris-HCl 
pH8, 200 mM NaCl).  An SDS-PAGE gel was used to monitor the purity of each fraction; 
Coomassie blue staining was used for protein visualization.   
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In vitro Protein Cleavage 
Aliquots of purified His-S5a and His-Omi134-458  or His-OmiS/A were incubated together 
to monitor ant potential cleavage of S5a by Omi134-458.  3 μl aliquots of purified His-S5a and 9 μl 
of Omi assay buffer were transferred to microcentrifuge tubes and 3 μl of purified His-Omi134-
458 or His-OmiS/A was added. The reactions were incubated at 37°C for either 1, 2 or 3 hours and 
analyzed by SDS-PAGE followed by Coomassie blue staining to visualize the proteins. 
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RESULTS  
Yeast-Two Hybrid Assay to Test Selectivity of Interactions 
The yeast-two hybrid system was used to identify novel interactors for the “bait” protein 
Omi that could also serve as its substrate.  This system is based on the principle of structural 
exclusivity of transcription factor domains; transcription factors have distinct DNA binding and 
functional domains that can function in the absence of the other.  The vector constructs used for 
the bait and prey proteins are designed to generate fusion molecules, each containing one of the 
separate transcription factor domains. The bait proteins fused to the DNA binding domain and 
the prey proteins fused to the functional domain of the transcription factor.  Upon co-
transformation of these constructs in yeast, an interaction between the bait and prey proteins will 
generate a complex containing the separated transcription factor domains thus eliciting its 
activity and the transcription of a LacZ reporter gene.   
The related proteins, HtrA1 and Omi, were used as the “bait” and the C-terminus of S5a 
(S5a229-377), HAX-1, and ATPase cVI served as separate “prey” proteins for this screen.  Co-
transformed yeast cells were cultured and plated on U-H-W- + Glucose media.  Individual 
colonies for each bait-prey pair were selected for plating on U-H-W- + Galactose/Raffinose/X-
Gal media.  Positive interactions were identified through blue/white screening. Presence of blue 
colonies indicates activation of the LacZ gene that codes for β-galactosidase, which cleaves the 
X-Gal present in the media into a product that upon dimerization and oxidation forms a blue 
pigment.  All three bait proteins interacted with pGILDA-LexA-Omi, however pjG4-5-S5a229-377 
displayed the strongest interaction, which was determined by the intensity of the colony’s blue 
 15 
color.  Additionally, pJG4-5-ATPase cVI displayed an interaction with pGILDA-LexA-HtrA1, 
which was not seen with the other prey proteins screened.  This suggested a lack of specificity 
for the interaction with Omi and thus the protein was not chosen for further characterization. 
  
 
 
 
 
 
 
 
 
   
Figure 1: Screen for Omi Interactors in Yeast 
Yeast-two hybrid screen of pGILDA-LexA-Omi134-458 and pGILDA-LexA-HtrA1157-480 bait proteins with 
pJG4-5-S5a229-377, pJG4-5-Hax-1, and pJG4-5-ATPase-cVI prey proteins. pJG4-5-S5a229-377, pJG4-5-Hax-1 and 
pJG4-5-S5a229-377 are shown to interact with LexA-Omi134-458, pJG4-5-S5a229-377 displayed the strongest interaction; 
pJG4-5-ATPase-cVI is only prey protein to show an interaction with pGILDA-LexA-HtrA1157-480 in this screen.   
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Generation of Full Length Recombinant S5a Protein 
Sequence analysis of the S5a clone isolated from the HeLa cDNA library revealed that it 
only encoded the c-terminal portion of the S5a protein. This part included amino acids 229-377 
of S5a, and will be further referred to as S5a229-377.  
Full length S5a cDNA was generated by PCR using primers specific to the S5a 
nucleotide sequence that also contained restrictions sites that permitted cloning into the pJG4-5 
vector.  Upon cloning, this full-length construct was used in a secondary yeast-two hybrid screen 
to determine if the full-length pJG4-5-S5a would interact with pGILDA-Omi134-458. 
 
 
Secondary Yeast-Two Hybrid Interaction 
EGY48 yeast was co-transformed with a pGILDA-LexA-Omi134-458 “bait” construct and a 
full-length pJG4-5-S5a “prey” construct.  The recombinant yeast were cultured and plated on U-
H-W- + Glucose media.  Individual colonies were selected to inoculate U-H-W- + Galactose/XGal 
media.  Four individual clones of full-length S5a cDNA were used in the generation of “prey” 
constructs for yeast transformation. The c-terminal pJG4-5-S5a229-377 was included as a positive 
control and was the only clone species that displayed an interaction with pGILDA-LexA-Omi134-
458 in this screen. 
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Figure 2: Interaction of Omi134-458 and S5a in Yeast 
Yeast two-hybrid test for the interaction between LexA-Omi134-458 bait protein and full-length S5a prey 
protein.  Interaction between LexA-Omi134-458 and full-length S5a was not detected in the screen, C-terminal S5a229-
377 continues to display interaction with LexA-Omi134-458.  
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Yeast Two-Hybrid Interaction with Inactive Omi Protease 
OmiS/A cDNA, representing an inactive form of Omi that lacks serine protease activity, 
was cloned in to a pGILDA vector to generate a “bait” construct for use in yeast-two hybrid 
screening. Full-length S5a cDNA was used in the generation of a “prey” construct for yeast 
transformation. The recombinant yeast were cultured and plated on U-H-W- + Glucose media.  
Individual colonies were selected to inoculate U-H-W-  + Galactose/XGal media.  The full-length 
S5a showed an interaction with OmiS/A.  Additionally, the C-terminal S5a229-377 protein also 
displayed an interaction with the inactivated OmiS/A. 
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Figure 3: Interaction of OmiS2A and S5a in Yeast 
 Yeast two-hybrid system test of inactive LexA-OmiS/A bait protein and full-length S5a prey protein.  Interaction between LexA-OmiS/A and full-length S5aFL was detected; C-terminal S5a229-377 also displays strong interaction with LexA-OmiS2A. 
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In vitro Proteolytic Assay of S5a and Omi 
Purified His-S5a and His-Omi134-458 were incubated together at 37°C to determine if 
mature His-Omi134-458 cleaves His-S5a in vitro.  Samples of denatured and native His-S5a were 
incubated with active His-Omi134-458 respectively and then were subject to SDS-PAGE.  Samples 
containing solely His-S5a or His-Omi134-458 were used as controls.  The His-S5a control sample 
displayed no cleavage, where as both the denatured and native His-S5a incubations with active 
His-Omi134-458 showed reduction of full-length His-S5a and evidence of degradative products.  
The denatured His-S5a and His-Omi134-458 incubation displayed greater degradation than did the 
native His-S5a and His-Omi134-458 incubation, however substantial degradation of native His-S5a 
was still present.    
In vitro Proteolytic Assay of S5a and OmiS/A   
Another assay was also performed using His-S5a and inactive His-OmiS/A to show that 
active Omi134-458 is responsible for the observed in vitro cleavage.  Purified denatured or native 
His-S5a were incubated with His-OmiS/A respectively at 37°C to identify His-OmiS/A cleavage of 
S5a and then analyzed by SDS-PAGE and Coomassie Blue staining.  The control samples 
containing His-S5a and His-OmiS/A alone displayed no auto-cleavage.  Incubations of both 
denatured and native His-S5a displayed no His-OmiS/A cleavage of S5a.   
 21 
   
    
 
Figure 4: Differential Proteolytic Activity of Active and Inactive Omi on Recombinant S5a Protein 
Proteolytic assays conducted to demonstrate that an active serine protease, His-Omi134-548, is responsible for 
the observed in vitro cleavage of a His-S5a substrate.  Upon incubation with His-S5a, His-Omi134-458 displayed an 
ability to degrade the substrate in both its native and denatured form.  Evidence of degradation was absent from the 
incubations containing the inactive form of the serine protease, His-OmiS/A, thus suggesting that active His-Omi134-
458 is solely responsible for the observed degradation of the His-S5a substrate in this assay. 
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DISCUSSION   
Omi is a mitochondrial mammalian serine protease that is implicated in both caspase-
dependent and caspase-independent apoptosis.  Omi selectively binds and cleaves IAP, eliciting 
caspase action and the activation of the caspase-dependent apoptotic pathway.  Omi’s complete 
mechanism of action in the caspase-independent pathway is still unknown, however studies have 
shown that it cleaves the cytosolic anti-apoptotic protein Ped/pea-15 upon induction of the 
pathway (5,6). 
To further elucidate the function of Omi in the caspase-independent apoptotic pathway a 
yeast-two hybrid screen was performed to identify interactors of Omi that also serves as potential 
substrates.  Figure 1 reveals the results of this screen, in which the prey protein S5a229-377 
displayed the strongest interaction with Omi. The intensity of blue color associated with the 
S5a229-377 colonies prompted its selection for further study in characterizing an interaction with 
Omi. The lack of an observed interaction with a second protein bait, LexA-HtrA1, suggests that 
the interaction observed with LexA-Omi134-458 is specific given the high homology observed 
between the catalytic domains of HtrA1 and Omi. 
A sequence analysis of the S5a229-377 cDNA used to generate the “prey” construct 
revealed that only the C-terminal amino acids (229-377) were coded for by this partial cDNA.  
The interaction between this C-terminal S5a fragment and Omi does not provide sufficient 
support for an interaction between full-length S5a and Omi.  However it does suggest that a 
domain localized on the C-terminus of S5a would facilitate such an interaction with Omi.   
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Full length S5a cDNA was generated by PCR and then cloned into pJG4-5 to create a 
“prey” construct for a second yeast-two hybrid test with Omi.  The results of this test are 
presented in Figure 2 and display a lack of interaction between the full-length S5a and LexA-
Omi134-458.  It was hypothesized that if mature full-length S5a was a substrate of Omi then their 
interaction would result in the cleavage of S5a, thus preventing the formation of the bait-prey 
complex and the transcription of the LacZ reporter gene.  The interaction between C-terminal 
S5a229-377 with LexA-Omi134-458 further suggests that if S5a is a substrate of Omi, its cleavage site 
is located upstream of amino acid 229 or that the C-terminal fragment does not assume a 
conformation that permits cleavage.   
A “bait” construct was generated using the cDNA of OmiS/A, an inactive form of the 
protein with a missense mutation that changes the 306 serine residue to an alanine, which 
abolishes its protease activity.  A yeast-two hybrid test was performed with this “bait” and full-
length S5a as the “prey”.  The results of this screen are presented in Figure 3 and display an 
interaction between S5a and LexA-OmiS/A.  These results support the hypothesis that active Omi 
cleaves S5a preventing detection of an interaction during the yeast-two hybrid screen presented 
in Figure 2. S5a229-377 also displayed an interaction with the inactive LexA-OmiS/A, suggesting 
that the mutation of the Omi sequence did not disrupt the binding interaction of the two proteins, 
solely Omi’s ability to cleave the S5a substrate. 
To further characterize the biological significance of an Omi and S5a interaction, 
recombinant proteins were uses in an in vitro proteolytic assay. Both native and denatured forms 
of His-S5a were used to better understand the physiological implications of this protein-protein 
interaction.  There was significant degradation of both forms of His-S5a upon incubation with 
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active His-Omi134-458 at physiological temperatures, suggesting that cleavage of S5a by Omi is 
possible under in vivo conditions.   
To discount for the possibility of the observed degradation might be the result of sample 
contamination, the inactive form of the mitochondrial serine protease, His-OmiS/A, was also used 
for a second proteolytic assay.  No degradation of either form of His-S5a was observed in the 
presence of His-OmiS/A.  Thus the observed degradation of His-S5a is solely attributed to the 
serine protease activity of His-Omi134-458, given that the purification steps and reaction conditions 
for both proteolytic assays were identical.  This further supports the initial yeast-two hybrid test 
that suggests a protein-protein interaction between LexA-Omi134-458 and S5aFL.   
The data generated from this study support the notion that S5a is a protein substrate for 
the mitochondrial serine protease, Omi.  The cytosolic localization of S5a in both its free form 
and as a proteasome component suggests that this protein-protein interaction requires the release 
of Omi from the mitochondria.  This translocation occurs during induction of apoptosis, which 
suggests that Omi plays a role in the inactivation or degradation of the proteasome during 
apoptosis.  Further studies are required to characterize the complete mechanism of Omi’s action 
on S5a and to further elucidate the role of Omi in the caspase independent apoptotic pathway.  
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